CRA consultants named top IP professionals in the 2023 IAM Strategy 300
13 CRA consultants were recognized as leading IP strategy by Intellectual Asset Management (IAM). IAM Strategy 300: The World’s Leading IP Strategists lists...
CRA has assisted clients in intellectual property (IP) matters concerning products and services in the life sciences sector, including Hatch-Waxman and BPCIA matters. We have also addressed patent, trademark, and copyright infringement, trade secret misappropriation, and IP licensing. Our experts have quantified damages based on lost profit and reasonable royalty methods and provided opinions on irreparable harm. In addition, we have experience addressing other forms of relief, such as rescission and disgorgement.
Our understanding of the unique dynamics of different therapeutic areas informs assessments of commercial success as a secondary indicator of non-obviousness and the claimed nexus between patented technologies and product success.
Engagements
- 01Valuation of contributions to codeveloped intellectual propertyCRA was retained to serve as a neutral advisor to the Tribunal in an international arbitration involving a licensing dispute between two agricultural sciences...View engagement
- 02Damages analysis and evaluation of commercial success for a medical deviceCRA was retained on behalf of the Plaintiff in a patent infringement matter involving collection devices used for diagnostic and genetic testing. Dr. Gregory...View engagement
- 03Commercial success of pre-operative skin sterilization productsCRA was retained by the petitioner in an IPR proceeding at the Patent Trial and Appeal Board (PTAB) to determine whether there was evidence of commercial...View engagement